Matches in Wikidata for { <http://www.wikidata.org/entity/Q90016291> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q90016291 description "article scientifique publié en 2019" @default.
- Q90016291 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90016291 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90016291 description "scientific article published on 16 April 2019" @default.
- Q90016291 description "wetenschappelijk artikel" @default.
- Q90016291 description "наукова стаття, опублікована 16 квітня 2019" @default.
- Q90016291 name "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 name "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 type Item @default.
- Q90016291 label "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 label "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 prefLabel "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 prefLabel "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 P1433 Q90016291-5F1E13A9-9513-4DF0-848D-10BDB43DEE86 @default.
- Q90016291 P1476 Q90016291-D37E046E-E7D7-46E1-9D97-99EF387FFE20 @default.
- Q90016291 P2093 Q90016291-16E485B4-6066-482B-87D8-39E3DF28CBF9 @default.
- Q90016291 P2093 Q90016291-918457A8-EC61-4B7A-8BF8-0FF391296209 @default.
- Q90016291 P2093 Q90016291-BDDD2C88-8B03-42C6-BC2D-064A27DB68CF @default.
- Q90016291 P2093 Q90016291-C1C0B2FF-83D4-4484-BBB6-9BDE9B96BC29 @default.
- Q90016291 P2093 Q90016291-DC36793F-3D0D-4ABF-B4D6-9B200E762D27 @default.
- Q90016291 P304 Q90016291-360584E6-452E-4F90-8D34-B7DC2E91089C @default.
- Q90016291 P31 Q90016291-ADD93496-92AB-45BF-82A6-0BBF86E0C817 @default.
- Q90016291 P356 Q90016291-DE1F3C4D-84D0-4EAB-9B4B-15131AB55259 @default.
- Q90016291 P478 Q90016291-8F77918D-545C-49DB-8802-C05678F8ECFF @default.
- Q90016291 P577 Q90016291-1407344C-8415-4F09-BE8B-C13519523A83 @default.
- Q90016291 P698 Q90016291-9D06B60A-E67A-43D9-B53A-18271E273045 @default.
- Q90016291 P921 Q90016291-78ED56A0-1CFA-451E-83E1-442936F9811E @default.
- Q90016291 P921 Q90016291-8B1DEB1E-13A9-445A-B61C-D6FF50650A86 @default.
- Q90016291 P356 J.IJPHARM.2019.04.013 @default.
- Q90016291 P698 31002934 @default.
- Q90016291 P1433 Q6051539 @default.
- Q90016291 P1476 "CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells" @default.
- Q90016291 P2093 "Fanhui Kong" @default.
- Q90016291 P2093 "Kun Wei" @default.
- Q90016291 P2093 "Long Zhang" @default.
- Q90016291 P2093 "Xiao Luo" @default.
- Q90016291 P2093 "Yulian Yang" @default.
- Q90016291 P304 "340-349" @default.
- Q90016291 P31 Q13442814 @default.
- Q90016291 P356 "10.1016/J.IJPHARM.2019.04.013" @default.
- Q90016291 P478 "564" @default.
- Q90016291 P577 "2019-04-16T00:00:00Z" @default.
- Q90016291 P698 "31002934" @default.
- Q90016291 P921 Q18936 @default.
- Q90016291 P921 Q61231 @default.